[go: up one dir, main page]

MXPA05008490A - Combinaciones que contienen imidazopiridinas y su uso en el tratamiento de enfermedades gastrointestinales inflamatorias. - Google Patents

Combinaciones que contienen imidazopiridinas y su uso en el tratamiento de enfermedades gastrointestinales inflamatorias.

Info

Publication number
MXPA05008490A
MXPA05008490A MXPA05008490A MXPA05008490A MXPA05008490A MX PA05008490 A MXPA05008490 A MX PA05008490A MX PA05008490 A MXPA05008490 A MX PA05008490A MX PA05008490 A MXPA05008490 A MX PA05008490A MX PA05008490 A MXPA05008490 A MX PA05008490A
Authority
MX
Mexico
Prior art keywords
new
active compounds
pharmaceutically active
combinations
selected pharmaceutically
Prior art date
Application number
MXPA05008490A
Other languages
English (en)
Inventor
Senn-Bilfinger Joerg
Original Assignee
Altana Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Altana Pharma Ag filed Critical Altana Pharma Ag
Publication of MXPA05008490A publication Critical patent/MXPA05008490A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4375—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La presente invencion se refiere a nuevas combinaciones y nuevo uso de ciertos compuestos triciclicos de imidazo[1,2-a]piridina seleccionados en la prevencion o el tratamiento de enfermedades gastrointestinales causadas por medicamentos.
MXPA05008490A 2003-02-17 2004-02-16 Combinaciones que contienen imidazopiridinas y su uso en el tratamiento de enfermedades gastrointestinales inflamatorias. MXPA05008490A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP03003530 2003-02-17
PCT/EP2004/050138 WO2004071391A2 (en) 2003-02-17 2004-02-16 Imidazopyridines containing combinations and their use in treating gastrointestinal inflammatory disorders

Publications (1)

Publication Number Publication Date
MXPA05008490A true MXPA05008490A (es) 2005-10-18

Family

ID=32864938

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA05008490A MXPA05008490A (es) 2003-02-17 2004-02-16 Combinaciones que contienen imidazopiridinas y su uso en el tratamiento de enfermedades gastrointestinales inflamatorias.

Country Status (18)

Country Link
US (1) US20060154954A1 (es)
EP (1) EP1599175A2 (es)
JP (1) JP2006517952A (es)
KR (1) KR20050100671A (es)
CN (1) CN1747731A (es)
AR (1) AR044497A1 (es)
AU (1) AU2004212337A1 (es)
BR (1) BRPI0407541A (es)
CA (1) CA2515676A1 (es)
HR (1) HRP20050790A2 (es)
IS (1) IS8014A (es)
MX (1) MXPA05008490A (es)
NO (1) NO20054160L (es)
PL (1) PL377581A1 (es)
RS (1) RS20050603A (es)
TW (1) TW200418467A (es)
WO (1) WO2004071391A2 (es)
ZA (1) ZA200505451B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006117315A1 (en) * 2005-04-29 2006-11-09 Nycomed Gmbh Mutual prodrug compounds for use as antiinflammatory agents with gastrointestinal protecctive activity
EP1877410A1 (en) * 2005-04-29 2008-01-16 Nycomed GmbH Mutual prodrug compounds for use as antiinflammatory agents with gastrointestinal protective activity
EP2080513A1 (en) * 2008-01-16 2009-07-22 Schraermeyer, Ulrich, Prof. Dr. rer. nat Tetrahydropyridoethers for treatment of AMD

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5703073A (en) * 1995-04-19 1997-12-30 Nitromed, Inc. Compositions and methods to prevent toxicity induced by nonsteroidal antiinflammatory drugs
WO1998042707A1 (en) * 1997-03-24 1998-10-01 Byk Gulden Lomberg Chemische Fabrik Gmbh Tetrahydropyrido compounds
PT1115725E (pt) * 1998-09-23 2003-06-30 Altana Pharma Ag Tetra-hidropiridoeteres
WO2000026217A1 (en) * 1998-11-03 2000-05-11 Byk Gulden Lomberg Chemische Fabrik Gmbh Imidazonaphthyridines
EP1173439B1 (en) * 1999-04-17 2003-05-21 ALTANA Pharma AG Haloalkoxy imidazonaphthyridines
AU783724B2 (en) * 2000-03-29 2005-12-01 Altana Pharma Ag Tricyclic imidazopyridines
ATE311389T1 (de) * 2000-03-29 2005-12-15 Altana Pharma Ag Wirkstoffvorläufer von imidazopyridin-derivaten
CN1221554C (zh) * 2000-03-29 2005-10-05 奥坦纳医药公司 治疗胃肠疾病的吡喃并[2,3－c]咪唑并[－1,2－a]吡啶衍生物及药物组合物
BR0109542A (pt) * 2000-03-29 2003-06-10 Altana Pharma Ag Derivados de imidazopirina alquilados
MXPA03003706A (es) * 2000-10-25 2005-01-25 Altana Pharma Ag Imidazopiridinas polisustituidas, como inhibidores de secrecion gastrica.
CZ20032398A3 (cs) * 2001-03-08 2004-02-18 Astrazeneca Ab Nové použití derivátů 6-karboxamidoimidazo [1,2-a] pyridinu
TWI295575B (en) * 2002-04-24 2008-04-11 Altana Pharma Ag Nitrosated imidazopyridines

Also Published As

Publication number Publication date
CA2515676A1 (en) 2004-08-26
WO2004071391A3 (en) 2005-05-12
TW200418467A (en) 2004-10-01
EP1599175A2 (en) 2005-11-30
RS20050603A (sr) 2007-09-21
BRPI0407541A (pt) 2006-02-14
HRP20050790A2 (en) 2006-12-31
KR20050100671A (ko) 2005-10-19
AU2004212337A1 (en) 2004-08-26
WO2004071391A2 (en) 2004-08-26
JP2006517952A (ja) 2006-08-03
NO20054160L (no) 2005-11-14
NO20054160D0 (no) 2005-09-07
US20060154954A1 (en) 2006-07-13
CN1747731A (zh) 2006-03-15
IS8014A (is) 2005-09-08
AR044497A1 (es) 2005-09-14
ZA200505451B (en) 2006-08-30
PL377581A1 (pl) 2006-02-06

Similar Documents

Publication Publication Date Title
IL267381A (en) A pharmaceutical preparation containing dextromethorphan and quinidine for the treatment of nervous disorders
WO2004006858A3 (en) Compounds, compositions, and methods employing same
TW200503719A (en) Pyridino [1,2-a] pyrimidin-4-one compounds as anticancer agents
WO2003096990A3 (en) Protein cages for the delivery of medical imaging and therapy
PT1416935E (pt) Derivados de 4-amino-6-fenil-pirrolo[2,3-d]pirimidina
HUP0401104A3 (en) Beta-aminoacyl tetrahydroimidazo[1,2-a]pyrazines and tetrahydrotriazolo[4,3-a]pyrazines as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes and pharmaceutical compositions containing them
MXPA05010819A (es) Uso de antagonistas de opioide perifericos, especialmente metilnaltrexona para tratar sindrome de intestino irritable.
EP1631297A4 (en) TREATMENT OF IMMUNOSTIC DISEASES WITH ACTIVE VITAMIN D COMPOUNDS ALONE OR IN COMBINATION WITH OTHER THERAPEUTICS
WO2002099388A3 (en) Benzodiazepine bradykinin antagonists
WO2005037323A3 (en) Use of gro to treat or prevent inflammation
EP2161037A3 (en) Camptothecin-Somatostatin conjugates
ID29790A (id) PENGGUNAAN IMIDAZO(1,5-a)-PIRIDO(3,2-e)-PIRAZINON SEBAGAI OBAT
ZA201000581B (en) 1,2,3,4-tetrahydropyrrolo[1,2-a]pyrazine-6-carboxamide and 2,3,4,5-tetrahydropyrrolo[1,2-a][1,4]-diazepine-7-carboxamide derivatives,preparation and therapeutic use thereof
MY136822A (en) Derivatives of [6, 7-dihydro-5h-imidazo[1,2-a]imidazole-3-sulfonylamino]-propionamide and their use as inhibitors upon the interaction of cams and leukointegrins
MXPA05008490A (es) Combinaciones que contienen imidazopiridinas y su uso en el tratamiento de enfermedades gastrointestinales inflamatorias.
MXPA03008894A (es) Uso de compuestos de imidazo[1,2-a]-piridin-3-il-amidas e imidazo [1,2-a]-piridin-3-il-aminas sustituidas como medicamentos.
WO2004010924A3 (en) Pyrroloquinoline quinone drugs as a neuroprotectant and methods of use thereof
WO2002076930A3 (en) Substituted diarylureas as stimulators for fas-mediated apoptosis
AU2003255843A1 (en) 1,3-thiazolin-4-ones as therapeutic compounds in the treatment of pain
PT1718651E (pt) Derivados 7h-pirrolopirimidina
PL1668021T3 (pl) Nowe związki tioksylozy, sposób ich przygotowania, zawierające je kompozycje farmaceutyczne i ich zastosowanie w lecznictwie
WO2004012732A3 (en) Use of a proteasome inhibitor in the treatment of endothelial dysfunction and/or in a low-dose proteasome inhibitor therapy
IL174134A0 (en) Use of a protein in the preparation of a medicament for treatment of fibrotic diseases
AU2001292500A1 (en) 1,2,5,10-tetrahydropyridazino(4,5-b)quinoline-1,10-diones and their use for the treatment of pain
HK1089385A (en) Treatment of immune-mediated disorders with active vitamin d compounds alone or in combination with other therapeutic agents